Literature DB >> 8043942

Insulin resistance and hypertension in the elderly. Optimal drug therapy.

G Paolisso1, A Gambardella, D Galzerano, M Varricchio.   

Abstract

Numerous trials have demonstrated the negative effects of some antihypertensive drugs upon glucose handling. Such findings seem particularly interesting in aged hypertensive patients who are also insulin resistant and affected by physiological changes in the renal and cardiovascular systems. It appears that calcium channel blockers and angiotensin converting enzyme (ACE) inhibitors are the most appropriate drugs to lower blood pressure in aged insulin-resistant hypertensive patients. All calcium channel blockers studied have displayed similar metabolic effects, while among the ACE inhibitors studied, lisinopril was associated with the best metabolic responses. beta-Blockers and thiazide diuretics have strong negative effects on glucose handling. Further studies are needed in order to investigate the metabolic effects of alpha 1-antagonists in aged patients with insulin resistance and hypertension.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8043942     DOI: 10.2165/00002512-199404050-00005

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  37 in total

1.  ACE inhibition improves insulin-sensitivity in aged insulin-resistant hypertensive patients.

Authors:  G Paolisso; A Gambardella; M Verza; A D'Amore; S Sgambato; M Varricchio
Journal:  J Hum Hypertens       Date:  1992-06       Impact factor: 3.012

2.  Insulin controlling calcium distribution in muscle and fat cells.

Authors:  T Clausen; J Elbrink; B R Martin
Journal:  Acta Endocrinol Suppl (Copenh)       Date:  1974

Review 3.  Modulation of the action of insulin in relation to the energy state in skeletal muscle tissue: possible involvement of kinins and prostaglandins.

Authors:  G J Dietze
Journal:  Mol Cell Endocrinol       Date:  1982-02       Impact factor: 4.102

4.  Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients.

Authors:  T Pollare; H Lithell; I Selinus; C Berne
Journal:  BMJ       Date:  1989-04-29

Review 5.  Insulin, insulin sensitivity and hypertension.

Authors:  P Ferrari; P Weidmann
Journal:  J Hypertens       Date:  1990-06       Impact factor: 4.844

6.  Improvement of impaired postoperative insulin action by bradykinin.

Authors:  K W Jauch; B Günther; W Hartl; K Rett; M Wicklmayr; G Dietze
Journal:  Biol Chem Hoppe Seyler       Date:  1986-03

7.  Metabolic effects of lacidipine: a placebo-controlled study using the euglycaemic hyperinsulinaemic clamp.

Authors:  A D Morris; R Donnelly; J M Connell; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1993-01       Impact factor: 4.335

Review 8.  Calcium channel blockers in geriatric hypertension.

Authors:  D G Vidt; R A Borazanian
Journal:  Geriatrics       Date:  1991-01

9.  Mechanisms of insulin resistance in aging.

Authors:  R I Fink; O G Kolterman; J Griffin; J M Olefsky
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

10.  Insulin and glyburide increase cytosolic free-Ca2+ concentration in isolated rat adipocytes.

Authors:  B Draznin; M Kao; K E Sussman
Journal:  Diabetes       Date:  1987-02       Impact factor: 9.461

View more
  1 in total

1.  Effect of SGLT-2 inhibitor, empagliflozin, on blood pressure reduction in Chinese elderly hypertension patients with type 2 diabetes and its possible mechanisms.

Authors:  Lan Cheng; Qianyu Fu; Longhua Zhou; Yuqin Fan; Fenfen Liu; Yuanyuan Fan; Xin Zhang; Weiqing Lin; Xiaohe Wu
Journal:  Sci Rep       Date:  2022-03-03       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.